136 related articles for article (PubMed ID: 15363301)
21. Sentinel node localization in breast carcinoma.
Haider MH; Khaliq T; Ahmed N; Shah SA; Rasheed R; Fatima S; Jaffery RA
J Coll Physicians Surg Pak; 2005 Apr; 15(4):215-7. PubMed ID: 15857593
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue.
Eldrageely K; Vargas MP; Khalkhali I; Venegas R; Burla M; Gonzalez KD; Vargas HI
Am Surg; 2004 Oct; 70(10):872-5. PubMed ID: 15529840
[TBL] [Abstract][Full Text] [Related]
23. Is a lymph node detected by the dye-guided method a true sentinel node in gastric cancer?
Osaka H; Yashiro M; Sawada T; Katsuragi K; Hirakawa K
Clin Cancer Res; 2004 Oct; 10(20):6912-8. PubMed ID: 15501969
[TBL] [Abstract][Full Text] [Related]
24. [Efficiency of lymphatic mapping by intradermal injection of vital blue dye for sentinel node identification in T1-2 N0-1 M0 stage breast cancer patients].
Kokhreidze I; Nemsadze G; Gersamia G; Dzagnidze G; Janjalia M
Georgian Med News; 2005 Apr; (121):7-10. PubMed ID: 15908713
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting false-negative breast sentinel node biopsy in Chinese patients.
Chok KS; Suen DT; Lim FM; Li GK; Kwong A
ANZ J Surg; 2007 Oct; 77(10):866-9. PubMed ID: 17803550
[TBL] [Abstract][Full Text] [Related]
26. The accuracy of intraoperative frozen section analysis of the sentinel lymph nodes during breast cancer surgery.
Khalifa K; Pereira B; Thomas VA; Mokbel K
Int J Fertil Womens Med; 2004; 49(5):208-11. PubMed ID: 15633476
[TBL] [Abstract][Full Text] [Related]
27. [Sentinel nodes identification efficacy prognostic criteria in breast cancer].
Kokhreidze ID; Nemsadze GG; Gersamiia GK; Dzagnidze GB; Dzhandzhaliia MT
Georgian Med News; 2005 Feb; (119):31-4. PubMed ID: 15834176
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients.
Nour A
Breast J; 2004; 10(5):388-91. PubMed ID: 15327490
[TBL] [Abstract][Full Text] [Related]
29. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?
Golshan M; Nakhlis F
Breast J; 2006; 12(5):428-30. PubMed ID: 16958960
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of intraoperative imprint cytology for sentinel lymph node evaluation in the treatment of breast carcinoma.
Cox C; Centeno B; Dickson D; Clark J; Nicosia S; Dupont E; Greenberg H; Stowell N; White L; Patel J; Furman B; Cantor A; Hakam A; Ahmad N; Diaz N; King J
Cancer; 2005 Feb; 105(1):13-20. PubMed ID: 15605359
[TBL] [Abstract][Full Text] [Related]
31. Sentinel node biopsy in breast cancer: five years experience from Denmark.
Christiansen P; Friis E; Balslev E; Jensen D; Møller S;
Acta Oncol; 2008; 47(4):561-8. PubMed ID: 18465323
[TBL] [Abstract][Full Text] [Related]
32. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy. Preferred method of axillary staging for breast cancer.
Tuttle TM
Minerva Ginecol; 2005 Jun; 57(3):293-303. PubMed ID: 16166937
[TBL] [Abstract][Full Text] [Related]
34. Comparison of blue dye and isotope with blue dye alone in breast sentinel node biopsy.
Syme DB; Collins JP; Mann GB
ANZ J Surg; 2005 Sep; 75(9):817-21. PubMed ID: 16174001
[TBL] [Abstract][Full Text] [Related]
35. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
[TBL] [Abstract][Full Text] [Related]
36. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
Gipponi M
Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
[TBL] [Abstract][Full Text] [Related]
37. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes.
Heyns CF; Theron PD
BJU Int; 2008 Aug; 102(3):305-9. PubMed ID: 18410439
[TBL] [Abstract][Full Text] [Related]
39. Three-axillary lymph node sampling for the prediction of nonsentinel node metastases in breast cancer patients with sentinel node metastases.
Motomura K; Egawa C; Komoike Y; Nagumo S; Koyama H; Inaji H
Ann Surg Oncol; 2006 Jul; 13(7):985-9. PubMed ID: 16788761
[TBL] [Abstract][Full Text] [Related]
40. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.
Wagner A; Schicho K; Glaser C; Zettinig G; Yerit K; Lang S; Klug C; Leitha T
J Craniomaxillofac Surg; 2004 Dec; 32(6):343-9. PubMed ID: 15555515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
